Tag: #Global Trends

In late 2025, the pharmaceutical landscape saw a strategic shift as Emmaus Life Sciences officially transferred the commercial rights of... Read more

Strategic price cuts to bolster market dominance The Danish pharmaceutical giant Novo Nordisk has significantly reduced the price of its... Read more

Unexpected setback from the U.S. regulator In a surprising turn of events, Sanofi received a Complete Response Letter (CRL) from... Read more

Efficacy shortfall in DUPLEX-AD study Johnson & Johnson (J&J) has decided to halt the Phase 2 clinical trial of its... Read more

Synergy between G4 Stabilizer and leading ADC technology Senhwa Biosciences has reached a clinical milestone by initiating a Phase 1b... Read more

Strategic partnership for advanced biomanufacturing Transcenta Therapeutics and EirGenix Inc. have entered into a strategic non-exclusive licensing agreement, granting EirGenix... Read more

A pivotal step toward Phase 1 clinical trials Akari Therapeutics has officially launched GMP (Good Manufacturing Practice) activities for its... Read more

Legal battle over federal grants for child health The American Academy of Pediatrics (AAP) has filed a lawsuit against the... Read more

The European Commission has officially granted marketing authorization for Wayrilz (rilzabrutinib), a pioneering oral therapy for adults with immune thrombocytopenia... Read more